Life Sciences Real Estate. Accelerated.
For emerging and established life sciences companies, speed to market is your goal - but with an historically low supply of suitable building inventory, the challenges of identifying, negotiating and executing a real estate solution are a hurdle to getting there. For owners, if you want to provide a viable option for this growth market, you need to speak the language and understand the financial and operational requirements of these specialized tenants.
Between them, the team of Joe Fetterman, Mike Brown and Clifford Brechner have specialized in life sciences real estate for 40 years, assisting clients with changing real estate requirements at key stages of growth. We offer extensive experience with strategic planning, site selection, transaction structuring and lease negotiation and documentation. In addition, our team is supported by the Colliers International Life Sciences Practice group covering the principal life science clusters across the US. We partner regularly with economic incentives consultants, process engineers and design/build specialists to support our clients' lab and manufacturing facility requirements.
We have experience with cGMP process manufacturing facilities in a variety of scales including:
- Biologics Manufacturing
- CAR-T and UCAR-T Manufacturing
- Vector Manufacturing
- Regenerative Cell Manufacturing
- OSD Manufacturing
- Parenteral Manufacturing
Our Expertise in Action
UCART Manufacturing Facility Site Selection
Colliers International recently structured a lease for Cellectis, a Paris based clinical-stage biopharmaceutical company, to create an 82,000 square foot commercial-scale manufacturing facility named IMPACT (Innovative Manufacturing Plant for Allogeneic Cellular Therapies) in Raleigh, North Carolina, for clinical and commercial production of Cellectis’ leading allogeneic UCART products.
With products in clinical trials, the Cellectis team was under time pressure to identify and build out a US manufacturing plant that would enable them to meet their manufacturing and marketing timeline. The search was limited to the East Coast to enable easy access to Paris. Key factors informing the search were depth of skilled workforce, cost of living, suitable building configuration and infrastructure...read more
Disposition of a Clinical Scale Biologics Manufacturing Facility
The Colliers Life Sciences Group was tasked with packaging and selling the NEOSE Technologies process facility, a 50,000-square-foot biologics manufacturing facility with two 3,000 Litre Mammalian Cell Manufacturing Sites, back within the industry to a company with a pipeline of products in the clinical stages of development. The facility was already 10 years old at the date of sale.
We identified through substantial research the names of those companies who were in Phases I, II and III with a strategy to develop and manufacture their product internally and not contract with a CMO....read more
Regenerative Cell Manufacturing Site Search
Tengion is a development-stage regenerative medicine company that required a first-of-its-kind facility utilizing current good manufacturing practices (cGMP) to manufacture autologous cells for the regeneration of bladder cells. The building required spaces for quality assurance, quality control, tissue culture and an open sterile manufacturing room for an incubator farm to produce the replacement bladders.
Tengion hired the Colliers team to perform a site-selection survey with a comparative analysis between two states, Pennsylvania and North Carolina. The site had to be free of vibrations that might impact the analytical equipment, have the potential to accommodate 2,000 amps of power, offer access to dark fiber and provide sufficient equivalent dwelling units (EDUs) to...read more
Science Park at Yale in New Haven, CT
The global Life Sciences Practice Group at Colliers spans multiple markets. In Connecticut, LSPG retains sole leasing responsibility for Science Park at Yale, a large research park that is the former manufacturing center of the Winchester Repeating Arms Company.
Colliers has worked with ownership and tenants to keep the complex occupied, productive and vibrant for a decade. To date, more than 150,000 square feet in the complex has been leased at a value of more than $20 million. Long term representation of the property has included transactions for lab and vivarium space with companies in various phases of their development cycle...read more
Stay in Touch
Stay ahead of the curve with our in-depth research reports, innovative thought leadership pieces, educational content and more covering the life sciences sector in the Greater Philadelphia region. Subscribe to our emails.
Executive Vice President | Healthcare and Life Sciences
Joe joined Colliers International in 2012 to lead and grow Colliers’ Office Brokerage Division. Today he focuses on providing strategic solutions to local, national and global Health Care, Life Sciences and Corporate clients. Joe’s background in architecture, real estate development and financial analysis provides clients with an experienced professional and strategic leader who integrates complex factors to create successful results for clients
Joe is a Healthcare Fellow and serves on Colliers National Healthcare Services and Life Sciences Steering Committees.
Clifford Brechner joined Colliers in 2019 to focus his talents in the fast-growing Philadelphia Life Sciences division.
Clifford comes to Colliers with more than 35 years of experience leading companies with revenues in excess of $10 million. For the past 20 years Brechner has led ventures within the analytical laboratory and quality assurance industry, making him exceptionally suited to help laboratory clients navigate their complicated real estate needs in an ever-changing market.
Clifford is a native of New York and currently resides in Bryn Mawr with his wife and two children.